5.3 Pediatric Pulmonary Arterial Hypertension, Cor Pulmonale & Eisenmenger Syndrome

5.3 Pediatric Pulmonary Arterial Hypertension, Cor Pulmonale & Eisenmenger Syndrome

Clinical Core: Pediatric pulmonary hypertension (PH) encompasses a heterogeneous spectrum of vascular diseases ranging from idiopathic arterial remodeling to congenital shunt-mediated vascular injury. Untreated chronic pulmonary vascular resistance elevation leads inexorably to right ventricular pressure overload, geometric remodeling, cor pulmonale, and eventual right heart failure. When systemic-to-pulmonary shunts remain uncorrected, end-stage plexogenic arteriopathy produces Eisenmenger syndrome—a condition where shunt reversal sustains systemic perfusion at the cost of chronic cyanosis, and where surgical closure of the defect is strictly fatal.

---

Diagnostic Criteria & Pediatric Etiologic Spectrum

Under updated World Symposium on Pulmonary Hypertension (WSPH) guidelines, pediatric pulmonary hypertension is defined hemodynamically by cardiac catheterization as:

1. Mean Pulmonary Artery Pressure (mPAP) > 20 mmHg at rest
2. Pulmonary Vascular Resistance Index (PVRI) >= 3.0 Wood Units·m² (in biventricular circulations)
3. Pulmonary Capillary Wedge Pressure (PCWP) <= 15 mmHg (differentiating pre-capillary from post-capillary PH)

Pediatric Clinical Etiologies

• Group 1: Pulmonary Arterial Hypertension (PAH): Idiopathic PAH (IPAH), heritable PAH (BMPR2, ACVRL1, ENG, SMAD9, TBX4 mutations), drug/toxin-induced, and PAH associated with congenital heart disease (CHD).
• Group 3: Developmental & Chronic Lung Diseases: The largest pediatric subgroup in infancy, including Bronchopulmonary Dysplasia (BPD) in extreme preterms, Congenital Diaphragmatic Hernia (CDH), and alveolar capillary dysplasia.
• Group 2 & 5: Left Heart Disease & Vascular Anomalies: Mitral stenosis (congenital arcade/parachute valve), cor triatriatum sinister, hypoplastic left heart syndrome variants, and progressive congenital pulmonary vein stenosis.

---

Quantitative Doppler Hemodynamics of the Pulmonary Circulation

Echocardiography offers precise, non-invasive quantification of pulmonary arterial pressures across multiple phases of the cardiac cycle:

1. Pulmonary Artery Systolic Pressure (PASP)

In the absence of right ventricular outflow tract (RVOT) obstruction or pulmonary valve stenosis, right ventricular systolic pressure (RVSP) equals PASP. Measured using the peak systolic tricuspid regurgitation (TR) velocity via the modified Bernoulli equation: $\text{PASP} = \text{RVSP} = 4(V_{\text{TR}})^2 + \text{RAP}$

• Estimation of Right Atrial Pressure (RAP) in Children: Subcostal long-axis interrogation of the inferior vena cava (IVC) at end-expiration:
  • Normal (3–5 mmHg): IVC normal diameter for age; collapsibility index >50%.
  • Mildly to Moderately Elevated (8–10 mmHg): IVC mildly dilated; collapsibility index <50%.
  • Severely Elevated (15 mmHg): IVC markedly dilated and plethoric with 0% respiratory collapse, accompanied by prominent diastolic flow reversal in the hepatic veins.

2. Mean & End-Diastolic Pulmonary Artery Pressures (mPAP & PAEDP)

Continuous-wave Doppler interrogation of the pulmonary regurgitation (PR) jet from the PSAX aortic base view yields two distinct pressure estimates:

• Mean Pulmonary Artery Pressure (mPAP): Calculated from the early peak diastolic PR velocity: $\text{mPAP} = 4(V_{\text{PR\_early}})^2 + \text{RAP}$
• Pulmonary Artery End-Diastolic Pressure (PAEDP): Calculated from the late end-diastolic PR velocity (immediately preceding the next ventricular contraction): $\text{PAEDP} = 4(V_{\text{PR\_end}})^2 + \text{RAP}$

3. Pulmonary Artery Acceleration Time (PAAT) & RVOT Flow Profiles

Pulsed-wave Doppler sampled in the RVOT immediately proximal to the pulmonary valve cusps (with the sample volume placed parallel to flow) evaluates the rate of pressure buildup in the pulmonary trunk:

• Normal Velocity Envelope: Smooth, symmetric, parabolic contour with a prolonged acceleration time (PAAT > 100–120 ms in children).
• Pulmonary Hypertension Waveform: Elevated pulmonary vascular impedance reflects pressure waves back toward the RV during early systole, causing:
  • Markedly shortened PAAT (<90 ms; <60 ms indicates severe PH).
  • Midsystolic Deceleration Notch ("Flying W" or Spike-and-Dome Sign): Pathognomonic dip in flow velocity during mid-systole produced by reflected wave cancellation.
  • PAAT / RV Ejection Time (RVET) Ratio: Normal is >0.32; a ratio <0.30 correlates strongly with elevated PVRI.

Normal RVOT Envelope:             Pulmonary Hypertension Envelope:
      /\                                /\
     /  \                              /  \  /\   <-- Midsystolic Notch ('Flying W')
    /    \                            /    \/  \
   /______\                          /__________\
  [PAAT > 100 ms]                   [PAAT < 80 ms]

---

Interventricular Septal Curvature Mechanics: "D-Shaped" Left Ventricle

The geometrical architecture of the interventricular septum (IVS) observed in the parasternal short-axis view at the mid-papillary level dynamically reflects the instantaneous transseptal pressure and volume gradient:

• Normal Geometry: Left ventricular pressure exceeds right ventricular pressure throughout both systole and diastole. The septum remains convex toward the RV, preserving a circular LV cross-section throughout the entire cardiac cycle (Eccentricity Index = 1.0).
• Right Ventricular Volume Overload (e.g., Uncomplicated ASD, Severe TR/PR): The RV accommodates excess diastolic blood volume, causing diastolic expansion that flattens the IVS toward the LV strictly during end-diastole. In systole, as the LV generates systemic systolic pressure, the septum promptly rebounds rightward, restoring a normal circular contour.
• Right Ventricular Pressure Overload (Pulmonary Arterial Hypertension): Peak RV systolic pressure approaches or equals LV systolic pressure. The septum flattens or bows leftward into the LV cavity during end-systole (Systolic Eccentricity Index > 1.0).
• Suprasystemic Pulmonary Hypertension (Severe PAH / Eisenmenger): RV pressure exceeds LV pressure throughout the entire cardiac cycle. The septum remains persistently flattened, pancaking or convexly protruding into the LV cavity during BOTH systole and diastole.

RV Volume Overload (ASD)        RV Pressure Overload (PHTN)      Suprasystemic PHTN
┌────────────────────────┐      ┌────────────────────────┐      ┌────────────────────────┐
│ Diastole: Flat Septum  │      │ Diastole: Round Septum │      │ Diastole: Flat Septum  │
│ (D-shaped LV)          │      │                        │      │ (D-shaped LV)          │
│ Systole: Round Septum  │      │ Systole: Flat Septum   │      │ Systole: Inverted Septum│
│ (Circular LV restored) │      │ (D-shaped LV)          │      │ (Persistent Pancake)   │
└────────────────────────┘      └────────────────────────┘      └────────────────────────┘

---

Cor Pulmonale & Multi-Parametric Right Ventricular Systolic Assessment

Chronic pulmonary hypertension triggers compensatory RV concentric hypertrophy that transitions over time to maladaptive RV dilation, geometric distortion, and contractile failure (cor pulmonale). A complete pediatric echocardiographic assessment requires multi-parametric functional quantification:

1. Structural Remodeling & Wall Thickness

• Right Ventricular Hypertrophy (RVH): Quantified in the subcostal or PLAX view at end-diastole. The RV free wall thickness should be measured below the tricuspid valve leaflets, strictly excluding coarse trabeculations and epicardial adipose tissue. An end-diastolic wall thickness >5 mm in older children (>3 mm in neonates/infants) indicates pathologic RVH.
• RV Dilation: Quantified on the apical four-chamber view. Under normal conditions, the LV is apex-forming and the RV basal dimension is roughly two-thirds of the LV. In cor pulmonale, the RV dilates, becomes apex-forming, and the RV/LV basal diameter ratio exceeds 1.0.

2. Functional Quantification Modalities

---

Eisenmenger Syndrome: Pathogenesis, Cellular Remodeling & Shunt Reversal

Eisenmenger syndrome represents the ultimate, irreversible culmination of uncorrected congenital systemic-to-pulmonary shunts (such as large ventricular septal defects [VSDs], patent ductus arteriosus [PDA], atrioventricular septal defects [AVSDs], or unrepaired truncus arteriosus):

1. Histopathologic Cascade (Heath-Edwards Classification)

1. Medial Hypertrophy (Grade I): Exposure to systemic shear stress and massive pulmonary blood flow stimulates muscularization of previously non-muscular pulmonary arterioles.
2. Intimal Cellular Proliferation (Grade II): Myofibroblasts migrate into the subendothelial intima, narrowing arteriolar lumina.
3. Progressive Intimal Fibrosis (Grade III): Dense concentric "onion-skin" fibrosis produces irreversible luminal occlusion.
4. Plexiform Lesions & Arteritis (Grades IV–VI): Aneurysmal dilatation, glomeruloid endothelial proliferation (plexiform lesions), necrotizing arteritis, and generalized vascular obliteration. Beyond Grade III, vascular remodeling is pathologically fixed and irreversible.

2. The Hemodynamic Transition to Shunt Reversal

As pulmonary vascular resistance increases relentlessly, PVRI approaches and eventually surpasses systemic vascular resistance (SVR). The intracardiac pressure differential reverses:

• Initial Stage: Large left-to-right shunt with pulmonary overcirculation.
• Transitional Stage: High-pressure bidirectional shunting; systemic RV pressures equal LV pressures; patient's congestive heart failure symptoms paradoxically improve as pulmonary flood reduces.
• Eisenmenger Stage: PVRI exceeds SVR. Blood follows the path of least resistance: deoxygenated systemic venous return from the right heart shunts right-to-left across the anatomical defect directly into the systemic circulation, causing profound arterial desaturation and central cyanosis.

3. Clinical & Echocardiographic Hallmarks

• Murmur Dissolution: The classic, loud holosystolic murmur of a restrictive VSD or the continuous "machinery" murmur of a PDA completely disappears because the trans-defect pressure gradient approaches zero. On auscultation, only a soft early systolic flow murmur, an accentuated single or loud second heart sound (loud P2), and a high-pitched diastolic Graham Steell murmur of severe pulmonary regurgitation are audible.
• Low-Velocity Shunting: Color Doppler across the VSD or PDA displays low-velocity, bidirectional or predominantly right-to-left blue/red signals with minimal turbulence. Continuous-wave Doppler demonstrates low-velocity shunting (<2.0 m/s).
• Pulmonary Artery Pathology: Massive dilation of the main and branch pulmonary arteries with low-velocity forward flow, high risk of in situ pulmonary artery thrombosis, and peripheral pulmonary calcification.
• Systemic Manifestations: Chronic hypoxemia triggers secondary erythrocytosis (hematocrit often >60–65%), digital clubbing, hyperviscosity syndromes, headache, and paradoxical embolic stroke risks.

---

Multisystem Comparison Table: Right Heart Hemodynamic States

---

Clinical Pearls & Diagnostic Traps

[!WARNING] The Shunt Closure Fatality in Eisenmenger: When a patient develops Eisenmenger syndrome, surgical or transcatheter closure of the underlying defect is strictly contraindicated and often immediately fatal. The unrestrictive VSD or PDA acts as a critical "pop-off" safety valve that preserves left ventricular filling and systemic cardiac output at the expense of arterial desaturation. Closing the defect forces the failing right ventricle to pump against fixed, suprasystemic pulmonary vascular resistance, inducing acute, refractory right ventricular cardiovascular collapse.

[!IMPORTANT] The Timing of Septal Flattening: Always synchronize the parasternal short-axis sweep to the ECG:

• Flattening at end-diastole (onset of QRS) = Right Ventricular Volume Overload (e.g., ASD, pulmonary regurgitation).
• Flattening at end-systole (end of T-wave) = Right Ventricular Pressure Overload (Pulmonary Hypertension).
• Flattening across both systole and diastole = Suprasystemic Pulmonary Hypertension.

[!TIP] Optimizing RVOT Doppler for PAAT: To obtain an accurate PAAT measurement, place the pulsed Doppler sample volume in the center of the RVOT approximately 5 to 10 mm proximal to the pulmonary valve in the PSAX or RV outflow view. Ensure the Doppler beam is perfectly parallel to flow. Measure from the onset of flow ejection to the peak velocity point. Avoid placing the sample volume distal to the valve leaflets, where post-valvular turbulence can artifactually alter acceleration timing.